Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade
Authors
Turgeon, Nicole A.Iwakoshi, Neal N.
Phillips, Nancy E.
Meyers, William C.
Welsh, Raymond M.
Greiner, Dale L.
Mordes, John P.
Rossini, Aldo A.
UMass Chan Affiliations
Department of SurgeryDepartment of Pathology
Department of Medicine, Division of Endocrinology and Metabolism
Department of Medicine, Division of Diabetes
Graduate School of Biomedical Sciences
Document Type
Journal ArticlePublication Date
2000-08-18Keywords
Animals; Antibodies, Monoclonal; Blood Transfusion; CD40 Ligand; CD8-Positive T-Lymphocytes; Female; *Immune Tolerance; *Lymphocyte Depletion; Lymphocytic Choriomeningitis; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Skin Transplantation; Transplantation, HomologousLife Sciences
Medicine and Health Sciences
Metadata
Show full item recordAbstract
BACKGROUND: Treatment with a single donor-specific transfusion (DST) plus a brief course of anti-CD154 monoclonal antibody (mAb) prolongs skin allograft survival in mice. It is known that prolongation of allograft survival by this method depends in part on deletion of alloreactive CD8(+) T cells at the time of tolerance induction. Recent data suggest that infection with lymphocytic choriomeningitis virus (LCMV) abrogates the ability of this protocol to prolong graft survival. METHODS: To study the mechanism by which viral infection abrogates allograft survival, we determined (1) the fate of tracer populations of alloreactive transgenic CD8(+) T cells and (2) the duration of skin allograft survival following treatment with DST and anti-CD154 mAb in the presence or absence of LCMV infection. RESULTS: We confirmed that treatment of uninfected mice with DST and anti-CD154 mAb leads to the deletion of alloreactive CD8(+) T cells and is associated with prolongation of skin allograft survival. In contrast, treatment with DST and anti-CD154 mAb in the presence of intercurrent LCMV infection was associated with the failure to delete alloreactive CD8(+) T cells and with the rapid rejection of skin allografts. The number of alloreactive CD8(+) cells actually increased significantly, and the cells acquired an activated phenotype. CONCLUSIONS: Interference with the deletion of alloreactive CD8(+) T cells mediated by DST and anti-CD154 mAb may in part be the mechanism by which viral infection abrogates transplantation tolerance induction.Source
J Surg Res. 2000 Sep;93(1):63-9. Link to article on publisher's siteDOI
10.1006/jsre.2000.5962Permanent Link to this Item
http://hdl.handle.net/20.500.14038/32712PubMed ID
10945944Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1006/jsre.2000.5962